Evidence for a role of CaMKIV in the development of opioid analgesic tolerance

Shanelle W Ko1, Yongheng Jia, Hui Xu

  • 1Department of Physiology, Faculty of Medicine, University of Toronto, University of Toronto Centre for the Study of Pain, 1 King's College Circle, Medical Sciences Building Rm3342, Toronto, Canada, M5S 1A8.

Insights

Calcium-calmodulin-dependent protein kinase IV (CaMKIV) plays a key role in developing opioid analgesic tolerance. CaMKIV knockout mice showed reduced tolerance to morphine, indicating CaMKIV

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • cAMP response-element binding protein (CREB) is crucial for learning, memory, and addiction.
  • Calcium-calmodulin-dependent protein kinase IV (CaMKIV) phosphorylates CREB.

Purpose of the Study:

  • To investigate the role of CaMKIV in the development of opioid analgesic tolerance and physical dependence.

Main Methods:

  • Utilized CaMKIV-knockout (KO) mice and wild-type (WT) littermates.
  • Administered chronic morphine to assess analgesic tolerance and physical dependence.
  • Measured CREB phosphorylation, micro-opioid receptor expression/phosphorylation, and G-protein uncoupling.
  • Assessed changes in inhibitory transmission.

Main Results:

  • CaMKIV-KO mice exhibited significantly less analgesic tolerance to chronic morphine compared to WT mice.
  • No differences in physical dependence or acute morphine analgesia were observed between groups.
  • Chronic morphine-induced increase in phosphorylated CREB was absent in CaMKIV-KO mice.
  • CaMKIV-KO mice showed reduced G-protein uncoupling from the micro-opioid receptor after morphine treatment.
  • Morphine decreased inhibitory transmission more in CaMKIV-KO mice post-chronic exposure.

Conclusions:

  • CaMKIV is critically involved in the development of opioid analgesic tolerance.
  • CaMKIV does not appear to play a significant role in the development of physical dependence on morphine.
  • These findings highlight CaMKIV as a potential therapeutic target for managing opioid tolerance.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...